The Miami Project faculty is a multidisciplinary team comprised of both basic and clinical scientists with expertise in neuroscience. 

Read a Message from the Scientific Director, W. Dalton Dietrich, Ph.D.

     SOCIAL MEDIA 

    MARKETPLACE HIGHLIGHTS 

     ST. PATRICK'S DAY
     "LUCK OF THE IRISH"

    Visit our Shop today for more of our St. Patrick's Day Items

Eco-Friendly

Tote Bag

$3.49 each

Our broad scope of collaborative research is dedicated to finding new treatments for spinal cord injury.    

Read a Message from the Chairman, Barth A. Green, M.D.

Today I am going to share portions of a recent question and answer session with Dr. Mary Bartlett Bunge.  As often happens when I get together with her, our discussions go on for a while so I am including only a portion here.  In the near future, I will write up and share additional excerpts.

Since joining our team in 1989 with her late husband and former scientific director, Richard P. Bunge, she has been a research superstar for The Miami Project.  She has spent much of her career working with Schwann cells, and it is a discovery that she and Dr. Damien Pearse reported in 2004 that is the impetus for our application to the FDA for our first ever clinical trial involving Schwann cell transplantation.

MARC: We all know that you are a highly accomplished neuroscientist, but can you tell us what made you want to become a scientist in the first place?

Mary Bartlett Bunge, Ph.D.: When I was a young girl in Connecticut we lived in the woods and near a stream on which I rowed my little leaky rowboat.  As I saw many tadpoles swimming around, I wondered how they developed and grew.  When I was a little older I remember being in biology class and part of our exercise was to draw many types of one-celled animals (such as paramecia) and they enthralled me so much that I began to consider that biology would be more compelling than my strong artistic and fashion interests.

Accolades

Scientific Lecture Calendar

Events Calendar